Industry: Medical Devices & Consumables
Published Date: 2025-04-18
Pages: 100 Pages
Report ld: 4713145
Request Sample
Customized Report
Endoscopic Bariatric Therapy Devices Market Size(US$)

CAGR 2025-2031
8.9%
Market Size,2031
USD 260
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Endoscopic Bariatric Therapy Devices market size was US$ 151 million in 2024 and is forecast to a readjusted size of US$ 260 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Among the various developed Endoscopic Bariatric Therapy (EBT) devices, the intragastric balloon (IGB) is the most widely used in clinical settings. The IGB is inserted into the stomach via endoscopy, occupying space to reduce gastric volume and delay gastric emptying. This helps patients control appetite, reduce food intake, and facilitate weight loss. It is primarily indicated for individuals with a Body Mass Index (BMI) between 30 and 40 who have not achieved weight loss through diet and exercise, and it is also used as a bridge therapy before bariatric surgery. The IGB is reversible and typically removed endoscopically after six months. In recent years, advancements in technology have led to the development of next-generation EBT devices, such as adjustable balloons, biodegradable balloons, and endoscopic suturing techniques, providing safer, minimally invasive, and more personalized treatment options for obese patients.
The North America Endoscopic Bariatric Therapy Devices market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Endoscopic Bariatric Therapy Devices include Boston Scientific (Apollo Endosurgery), ReShape Lifesciences, Allurion, Helioscopie, Endalis, MEDSIL, Spatz Medical, Lexel, Districlass Medical, Silimed, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Endoscopic Bariatric Therapy Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Endoscopic Bariatric Therapy Devices market competitiveness, regional economic performance, and supply chain configurations.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Endoscopic Bariatric Therapy Devices market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Others in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Female in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Endoscopic Bariatric Therapy Devices value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Endoscopic Bariatric Therapy Devices Product Scope
1.2 Endoscopic Bariatric Therapy Devices by Type
1.2.1 Global Endoscopic Bariatric Therapy Devices Sales by Type (2020 & 2024 & 2031)
1.2.2 Intragastric Balloon
1.2.3 Others
1.3 Endoscopic Bariatric Therapy Devices by Application
1.3.1 Global Endoscopic Bariatric Therapy Devices Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Male
1.3.3 Female
1.4 Global Endoscopic Bariatric Therapy Devices Market Estimates and Forecasts (2020-2031)
1.4.1 Global Endoscopic Bariatric Therapy Devices Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Endoscopic Bariatric Therapy Devices Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Endoscopic Bariatric Therapy Devices Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Endoscopic Bariatric Therapy Devices Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Endoscopic Bariatric Therapy Devices Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Endoscopic Bariatric Therapy Devices Sales Market Share by Region (2020-2025)
2.2.2 Global Endoscopic Bariatric Therapy Devices Revenue Market Share by Region (2020-2025)
2.3 Global Endoscopic Bariatric Therapy Devices Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Endoscopic Bariatric Therapy Devices Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Endoscopic Bariatric Therapy Devices Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Endoscopic Bariatric Therapy Devices Market Size and Prospective (2020-2031)
2.4.2 Europe Endoscopic Bariatric Therapy Devices Market Size and Prospective (2020-2031)
2.4.3 China Endoscopic Bariatric Therapy Devices Market Size and Prospective (2020-2031)
2.4.4 Japan Endoscopic Bariatric Therapy Devices Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Endoscopic Bariatric Therapy Devices Historic Market Review by Type (2020-2025)
3.1.1 Global Endoscopic Bariatric Therapy Devices Sales by Type (2020-2025)
3.1.2 Global Endoscopic Bariatric Therapy Devices Revenue by Type (2020-2025)
3.1.3 Global Endoscopic Bariatric Therapy Devices Price by Type (2020-2025)
3.2 Global Endoscopic Bariatric Therapy Devices Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Endoscopic Bariatric Therapy Devices Sales Forecast by Type (2026-2031)
3.2.2 Global Endoscopic Bariatric Therapy Devices Revenue Forecast by Type (2026-2031)
3.2.3 Global Endoscopic Bariatric Therapy Devices Price Forecast by Type (2026-2031)
3.3 Different Types Endoscopic Bariatric Therapy Devices Representative Players
4 Global Market Size by Application
4.1 Global Endoscopic Bariatric Therapy Devices Historic Market Review by Application (2020-2025)
4.1.1 Global Endoscopic Bariatric Therapy Devices Sales by Application (2020-2025)
4.1.2 Global Endoscopic Bariatric Therapy Devices Revenue by Application (2020-2025)
4.1.3 Global Endoscopic Bariatric Therapy Devices Price by Application (2020-2025)
4.2 Global Endoscopic Bariatric Therapy Devices Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Endoscopic Bariatric Therapy Devices Sales Forecast by Application (2026-2031)
4.2.2 Global Endoscopic Bariatric Therapy Devices Revenue Forecast by Application (2026-2031)
4.2.3 Global Endoscopic Bariatric Therapy Devices Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Endoscopic Bariatric Therapy Devices Application
5 Competition Landscape by Players
5.1 Global Endoscopic Bariatric Therapy Devices Sales by Players (2020-2025)
5.2 Global Top Endoscopic Bariatric Therapy Devices Players by Revenue (2020-2025)
5.3 Global Endoscopic Bariatric Therapy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endoscopic Bariatric Therapy Devices as of 2024)
5.4 Global Endoscopic Bariatric Therapy Devices Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Endoscopic Bariatric Therapy Devices, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Endoscopic Bariatric Therapy Devices, Product Type & Application
5.7 Global Key Manufacturers of Endoscopic Bariatric Therapy Devices, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Endoscopic Bariatric Therapy Devices Sales by Company
6.1.1.1 North America Endoscopic Bariatric Therapy Devices Sales by Company (2020-2025)
6.1.1.2 North America Endoscopic Bariatric Therapy Devices Revenue by Company (2020-2025)
6.1.2 North America Endoscopic Bariatric Therapy Devices Sales Breakdown by Type (2020-2025)
6.1.3 North America Endoscopic Bariatric Therapy Devices Sales Breakdown by Application (2020-2025)
6.1.4 North America Endoscopic Bariatric Therapy Devices Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Endoscopic Bariatric Therapy Devices Sales by Company
6.2.1.1 Europe Endoscopic Bariatric Therapy Devices Sales by Company (2020-2025)
6.2.1.2 Europe Endoscopic Bariatric Therapy Devices Revenue by Company (2020-2025)
6.2.2 Europe Endoscopic Bariatric Therapy Devices Sales Breakdown by Type (2020-2025)
6.2.3 Europe Endoscopic Bariatric Therapy Devices Sales Breakdown by Application (2020-2025)
6.2.4 Europe Endoscopic Bariatric Therapy Devices Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Endoscopic Bariatric Therapy Devices Sales by Company
6.3.1.1 China Endoscopic Bariatric Therapy Devices Sales by Company (2020-2025)
6.3.1.2 China Endoscopic Bariatric Therapy Devices Revenue by Company (2020-2025)
6.3.2 China Endoscopic Bariatric Therapy Devices Sales Breakdown by Type (2020-2025)
6.3.3 China Endoscopic Bariatric Therapy Devices Sales Breakdown by Application (2020-2025)
6.3.4 China Endoscopic Bariatric Therapy Devices Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Endoscopic Bariatric Therapy Devices Sales by Company
6.4.1.1 Japan Endoscopic Bariatric Therapy Devices Sales by Company (2020-2025)
6.4.1.2 Japan Endoscopic Bariatric Therapy Devices Revenue by Company (2020-2025)
6.4.2 Japan Endoscopic Bariatric Therapy Devices Sales Breakdown by Type (2020-2025)
6.4.3 Japan Endoscopic Bariatric Therapy Devices Sales Breakdown by Application (2020-2025)
6.4.4 Japan Endoscopic Bariatric Therapy Devices Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Boston Scientific (Apollo Endosurgery)
7.1.1 Boston Scientific (Apollo Endosurgery) Company Information
7.1.2 Boston Scientific (Apollo Endosurgery) Business Overview
7.1.3 Boston Scientific (Apollo Endosurgery) Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Boston Scientific (Apollo Endosurgery) Endoscopic Bariatric Therapy Devices Products Offered
7.1.5 Boston Scientific (Apollo Endosurgery) Recent Development
7.2 ReShape Lifesciences
7.2.1 ReShape Lifesciences Company Information
7.2.2 ReShape Lifesciences Business Overview
7.2.3 ReShape Lifesciences Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.2.4 ReShape Lifesciences Endoscopic Bariatric Therapy Devices Products Offered
7.2.5 ReShape Lifesciences Recent Development
7.3 Allurion
7.3.1 Allurion Company Information
7.3.2 Allurion Business Overview
7.3.3 Allurion Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Allurion Endoscopic Bariatric Therapy Devices Products Offered
7.3.5 Allurion Recent Development
7.4 Helioscopie
7.4.1 Helioscopie Company Information
7.4.2 Helioscopie Business Overview
7.4.3 Helioscopie Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Helioscopie Endoscopic Bariatric Therapy Devices Products Offered
7.4.5 Helioscopie Recent Development
7.5 Endalis
7.5.1 Endalis Company Information
7.5.2 Endalis Business Overview
7.5.3 Endalis Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Endalis Endoscopic Bariatric Therapy Devices Products Offered
7.5.5 Endalis Recent Development
7.6 MEDSIL
7.6.1 MEDSIL Company Information
7.6.2 MEDSIL Business Overview
7.6.3 MEDSIL Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.6.4 MEDSIL Endoscopic Bariatric Therapy Devices Products Offered
7.6.5 MEDSIL Recent Development
7.7 Spatz Medical
7.7.1 Spatz Medical Company Information
7.7.2 Spatz Medical Business Overview
7.7.3 Spatz Medical Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Spatz Medical Endoscopic Bariatric Therapy Devices Products Offered
7.7.5 Spatz Medical Recent Development
7.8 Lexel
7.8.1 Lexel Company Information
7.8.2 Lexel Business Overview
7.8.3 Lexel Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Lexel Endoscopic Bariatric Therapy Devices Products Offered
7.8.5 Lexel Recent Development
7.9 Districlass Medical
7.9.1 Districlass Medical Company Information
7.9.2 Districlass Medical Business Overview
7.9.3 Districlass Medical Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Districlass Medical Endoscopic Bariatric Therapy Devices Products Offered
7.9.5 Districlass Medical Recent Development
7.10 Silimed
7.10.1 Silimed Company Information
7.10.2 Silimed Business Overview
7.10.3 Silimed Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Silimed Endoscopic Bariatric Therapy Devices Products Offered
7.10.5 Silimed Recent Development
7.11 Changzhou Panda Medical
7.11.1 Changzhou Panda Medical Company Information
7.11.2 Changzhou Panda Medical Business Overview
7.11.3 Changzhou Panda Medical Endoscopic Bariatric Therapy Devices Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Changzhou Panda Medical Endoscopic Bariatric Therapy Devices Products Offered
7.11.5 Changzhou Panda Medical Recent Development
8 Endoscopic Bariatric Therapy Devices Manufacturing Cost Analysis
8.1 Endoscopic Bariatric Therapy Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Endoscopic Bariatric Therapy Devices
8.4 Endoscopic Bariatric Therapy Devices Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Endoscopic Bariatric Therapy Devices Distributors List
9.3 Endoscopic Bariatric Therapy Devices Customers
10 Endoscopic Bariatric Therapy Devices Market Dynamics
10.1 Endoscopic Bariatric Therapy Devices Industry Trends
10.2 Endoscopic Bariatric Therapy Devices Market Drivers
10.3 Endoscopic Bariatric Therapy Devices Market Challenges
10.4 Endoscopic Bariatric Therapy Devices Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 281 million by 2032, at a CAGR of 8.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 158
USD 4900.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 281 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 120
USD 2900.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market size was US$ 156 million in 2025 and is forecast to reach a readjusted size of US$ 281 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 95
USD 4250.00
(Single User License)
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 156 million in 2025 and is projected to reach US$ 281 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 122
USD 3950.00
(Single User License)
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 151 million in 2024 and is forecast to a readjusted size of US$ 260 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published Date: 2025-04-18
Pages: 129
USD 3950.00
(Single User License)
The global market for Endoscopic Bariatric Therapy Devices was valued at US$ 151 million in the year 2024 and is projected to reach a revised size of US$ 260 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published Date: 2025-04-18
Pages: 93
USD 2900.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 260 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period.
Published Date: 2025-04-18
Pages: 164
USD 4900.00
(Single User License)
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 281 million by 2032, at a CAGR of 8.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 158
The global Endoscopic Bariatric Therapy Devices market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 281 million by 2032, at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 120
The global Endoscopic Bariatric Therapy Devices market size was US$ 156 million in 2025 and is forecast to reach a readjusted size of US$ 281 million by 2032 with a CAGR of 8.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 95
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 156 million in 2025 and is projected to reach US$ 281 million, growing at a CAGR of 8.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 122
The global market for Endoscopic Bariatric Therapy Devices was estimated to be worth US$ 151 million in 2024 and is forecast to a readjusted size of US$ 260 million by 2031 with a CAGR of 8.9% during the forecast period 2025-2031.
Published: 2025-04-18
Pages: 129
The global market for Endoscopic Bariatric Therapy Devices was valued at US$ 151 million in the year 2024 and is projected to reach a revised size of US$ 260 million by 2031, growing at a CAGR of 8.9% during the forecast period.
Published: 2025-04-18
Pages: 93
The global Endoscopic Bariatric Therapy Devices market is projected to grow from US$ 156 million in 2025 to US$ 260 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period.
Published: 2025-04-18
Pages: 164
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now